Annual hazard rates for early-stage endometrial carcinoma after postoperative radiotherapy under FIGO 2023 staging system: results from a population-based single-center cohort study
Journal of Gynecologic Oncology · 2026
DOI: 10.3802/jgo.2026.37.e107 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Lingxia Xin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing,…. Hauptthemen laut MEDLINE: Endometrial Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Peking Union Medical College Hospital Talent Cultivation Program, Ministry of Science and Technology of the People's Republic of China, Ministry of Science and Technology of the People’s Republic of China.
Abstract (Originalsprache)
OBJECTIVE: To investigate whether early-stage endometrial carcinoma (EC) patients have survival outcomes comparable to those of the general population, and further explore the dynamic recurrence/death surveillance value of International Federation of Gynecology and Obstetrics(FIGO) 2023 staging system. METHODS: This retrospective study analyzed FIGO 2009 stage I-II patients receiving postoperative radiotherapy at Peking Union Medical College Hospital in China (2000-2020), re-staged per FIGO 2023 staging system. Overall survival (OS) and disease-free survival (DFS) were assessed using Kaplan-Meier methods; mortality was compared to age-/sex-matched Chinese controls using standardized mortality ratios (SMRs); recurrence/death trajectories were modeled through annual hazard rates; FIGO 2023 recurrence prediction accuracy was assessed via receiver operating characteristics analysis. RESULTS: This study of 1222 EC patients revealed upstaging from FIGO 2009 to 2023 (IA→II: 27.2%; IB→II: 26.4%). OS rates were 97.7% (3-year), 94.9% (5-year), and 91.0% (10-year), with corresponding DFS rates of 93.4%, 87.4%, and 82.8%. Under FIGO 2023 staging system, recurrence risk peaked at 1.3 years (3.5%) and declined after 3 years. Mortality risk increased within 4 years, stabilizing at about 1.0% thereafter. IC/IIC stages showed the earliest/highest risk peaks. Stage IA1-IA2 required monitoring for late recurrences (>3 years), while IIC needed vigilance for delayed mortality (>3 years). FIGO 2023 staging system was an independent prognostic factor for recurrence prediction (area under the curve: 1-year=0.644; 3-year=0.612; 5-year=0.611). CONCLUSION: Early-stage EC patients had favorable prognosis. FIGO 2023 staging system exhibit excellent recurrence surveillance and prognostic prediction for these patients after postoperative radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. houxr@pumch.cn.
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. zhangfq@pumch.cn.
ORCID-Profile: Lingxia Xin, Kang Ren, Zihan Yan, Jiabin Ma, Wenhui Wang, Yunlong Sheng, Yaqi Wang, Xiaorong Hou, Fuquan Zhang
Förderung
- Peking Union Medical College Hospital Talent Cultivation Program
- Ministry of Science and Technology of the People's Republic of China
- Ministry of Science and Technology of the People’s Republic of China
Zitieren
APA
Xin, L., Ren, K., Yan, Z., Ma, J., Wang, W., Sheng, Y., Wang, Y., Hou, X., & Zhang, F. (2026). Annual hazard rates for early-stage endometrial carcinoma after postoperative radiotherapy under FIGO 2023 staging system: results from a population-based single-center cohort study. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e107
Vancouver
Xin L, Ren K, Yan Z, Ma J, Wang W, Sheng Y, et al. Annual hazard rates for early-stage endometrial carcinoma after postoperative radiotherapy under FIGO 2023 staging system: results from a population-based single-center cohort study. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e107
BibTeX
@article{Xin2026,
author = {Xin, Lingxia and Ren, Kang and Yan, Zihan and Ma, Jiabin and Wang, Wenhui and Sheng, Yunlong and Wang, Yaqi and Hou, Xiaorong and Zhang, Fuquan},
title = {Annual hazard rates for early-stage endometrial carcinoma after postoperative radiotherapy under FIGO 2023 staging system: results from a population-based single-center cohort study},
journal = {Journal of Gynecologic Oncology},
year = {2026},
doi = {10.3802/jgo.2026.37.e107}
}
EUVIMED